Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
5.17
+0.07 (1.37%)
Sep 8, 2026, 11:22 AM EDT - Market open
Cingulate Market Cap
Cingulate has a market cap or net worth of $75.18 million as of September 8, 2026. Its market cap has increased by 243.87% in one year.
Market Cap
75.18M
Enterprise Value
53.07M
1-Year Change
243.87%
Ranking
Category
Stock Price
$5.17
ChartMarket Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has increased from $64.29M to $75.18M, an increase of 16.95%. That is a compound annual growth rate of 3.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 75.18M | 156.37% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 78.75M |
| Gain Therapeutics | 78.56M |
| Dogwood Therapeutics | 77.84M |
| Rein Therapeutics | 76.70M |
| NeurAxis | 74.84M |
| Nutriband | 72.57M |
| Champions Oncology | 72.52M |
| Pliant Therapeutics | 71.83M |